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THREE cases of recovery from paraquat poisoning are reported. In cases of this
sort small amounts of a dilute preparation are not usually fatal. Larger amounts
of concentrated preparations are invariably fatal but with very small amounts of
concentrated preparations the outcome is often unpredictable. It is suggested that
in such cases all measures to prevent absorption, increase excretion, maintain the
patient and prevent progressive renal, hepatic and pulmonary damage are justified.
CASE REPORTS
Case No. I
A 33-year-old man was admitted to an Intensive Care Unit one hour after taking
about 30 ml. of "Weedol" (5 per cent paraquat) as well as a mixture of sedatives and
anti-epileptic tablets. He was a transvestite with a history of psychiatric treatment. On
admission he was given a litre of 7 per cent Bentonite by stomach tube. When seen
11 hours later, he was fully conscious. He was not jaundiced, had no mouth ulcers
and was afebrile. His chest was clear clinically. His blood pressure was 116/75 mm Hg.
His pulse was 80 per minute and regular. His blood urea was 33 mg%. Paraquat
levels in 2 urinary samples the day after admission were 470 ug/100 ml., and
180 ug/100 ml., respectively.
The patient passed no urine for 24 hours after admission, due to retention, but
passed adequate amounts after catheterization. He made a full recovery with no
evidence of renal or respiratory damage. A chest x-ray showed no active lung lesion
although there was a calcified focus in the left lower zone with some calcified left
hilar glands. The patient was still physically well five months after discharge when
he was readmitted following another overdose; this time he seemed to have avoided
paraquat!
Case No. 2
A 56-year-old man was admitted to an Intensive Care Unit 12 hours after takling a
mouthful of "Dextrone" weedkiller (a combination of paraquat and diquat) which he
spat out at once. Shortly afterwards gastric lavage was performed and after another
4 hours one litre of 7% Bentonite was instilled in a Casualty Department. On admission
he was fully conscious and appeared well, although he had begun to suffer from
diarrhoea a few hours before arrival. There was no mouth ulceration, no jaundice
and no abdominal tenderness. The chest was clear. The blood pressure was
170/80 mm Hg., and the pulse was 80 per minute. There was a low grade pyrexia
which persisted for 2 weeks. The day after admission the patient developed a sore
throat and dysphagia, later coughing up some blood. He passed only 100 ml. of urine
in the first 12 hours but thereafter produced adequate amounts. The blood urea was
170 mg/100 ml. on admission. It gradually fell to a normal level over a peiod of
3 weeks. The serum creatinine was 1.8 mg/100 ml. 5 days after admission. The
serum S.G.O.T. reached a level of 159 K units, L.D.H. 370 W.L. units and alkaline
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raised at any time. Serial chest x-rays showed no lung lesion. The serum paraquat was
not estimated. Urinary paraquat was measured in samples taken between the tenth and
sixteenth days. The highest level detected was only 21 ug/ 100 ml., and in several
samples no paraquat was found.
The patient made a good recovery despite developing thrombophlebitis in the right
axillary vein where he had had an initial intravenous infusion. He was discharged
eighteen days after admission and when seen 2 weeks later had a normal blood urea
and serum creatinine. One month later he remained well.
Case No. 3
A 52-year-old man was admitted to an Intensive Care Unit. He gave a history of
splashing his face and mouth with "Gramoxone W" (20 per cent paraquat) from a
can of weedkiller about 3 days before. He at once washed his face, mouth and hands.
The next day he developed discomfort in his mouth and throat and began to have
difficulty in swallowing. He had passed very little urine in the 2 days before admission.
On examination he was fully conscious and afebrile. He was slightly cyanosed and
had a rapid respiratory rate, but his chest was clinically clear. There was ulceration
of the buccal mucosa and severe ulceration of the mucosa over the fauces and
pharynx. He had difficulty in swallowing even saliva. The pulse was 120 per minute
and the blood pressure 120/80 mm Hg. There was no abdominal tenderness. The
blood urea on admission was 70 mg/100 ml. An Astrup test showed a respiratory
alkalosis. A chest x-ray showed no lesion. The serum paraquat level on admission
was 94 ug/100 ml. The urinary paraquat level was 197 ug/100 ml. The serum S.G.O.T.
was 65 K units but there was no other evidence of liver damage.
The patient remained almost anuric for 4 days after admission but thereafter
achieved satisfactory diuresis. He was treated with peritoneal dialysis for 6 days,
intravenous fluids, sedation and oxygen. His blood urea gradually fell to a normal
level. Six days after admission small amounts of paraquat were still present in the
urine. No paraquat was found in the dialysate at any stage. A chest x-ray 10 days
after admission showed a small patch of consolidation in the right lower zone, with
a small left-sided basal effusion. He was given a course of intramuscular penicillin.
Subsequent chest x-rays were clear. He was discharged sixteen days after admission.
A week later his blood urea was normal and a M.S.S.U. was clear of cells or protein.
3 months later, he remained well.
DISCUSSION
Paraquat and diquat are bipyridilium compounds much used in agriculture
as surface-contact herbicides. They are believed to be continuously reduced and
re-oxidized in the presence of chlorophyll with the gradual accumulation of
hydrogen peroxide to toxic levels. They are inactivated by contact with soil,
possibly because of the cation-capturing effect of silicates contained in it. There
is a minimum dose beneath which dietary paraquat causes no apparent damage
and an intermediate dose which on long term consumption produces pulmonary
fibrosis in animals (Conning et al, 1969; Daniel and Gage, 1966). Paraquat is
poorly absorbed, over 70 per cent appearing in the faeces, and in addition there
is evidence that it is degraded by microbiological action in the intestinal tract.
It is more rapidly absorbed in fasting than in recently fed animals (Clark et al,
1966) and this may also apply in cases of human poisoning (Greig, quoted by
Matthew et al, 1968). It is rapidly excreted in experimental animals (Daniel and
Gage, 1966) and this led to the suggestion that it is a "hit, and run" poison, since
the pulmonary lesions progressed in the absence of further dosage. However, in
man, it continues to be excreted for many days in the urine (Tompsett, 1970).
210'l'his species variation casts some doubt on the value of animal experiments.
The severe effects of poisoning by bipyridilium compounds are well known.
Although small amounts of "Weedol" (5 per cent paraquat) or paraquat and
diquat mixtures such as "Dextrone" do not appear to be fatal, herbicides with a
higher concentration, such as Gramoxone W (20 per cent paraquat) have a very
bad record. The "typical victim" takes a mouthful of 20 per cent paraquat,
which he at once spits out, but he later dies, usually of renal or late progressive
pulmonary damage, although gastro-intestinal, hepatic and myocardial lesions are
also often found. However, the outcome is not always predictable and several
patients have recovered fully. Some die in spite of intensive treatment with forced
diuresis, and haemodialysis or peritoneal dialysis. Others recover without treatment.
(See Malone et al, 1971, for a comprehensive review of their own cases and the
literature). In general, the more severe the objective evidence of organ damage,
the less likely the patient is to survive. The absence of pulmonary lesions makes
survival more likely. Steroids and immuno-suppression have been used in an effort
to halt renal and late pulmonary damage, but it is admitted that there is no
convincing evidence of their value. Very little paraquat is removed by dialysis
(Tompsett, 1970; Carson, 1972), although removal by haemodialysis may be
comparable to urinary excretion. Urinary excretion may be increased by forced
diuresis (Kerr et al, 1968). In the presence of acute renal failure due to paraquat-
induced tubular necrosis, dialysis may of course be essential to maintain life,
and it is then the only route of excretion available.
Of the cases reported here, the first two belong to the category in which recovery
may be expected, since small amounts of paraquat in low concentration were
taken. The third case belongs to the category in which the outcome is very often
fatal. Treatment with peritoneal dialysis, although it did not remove detectable
amounts of paraquat, will have lessened the systemic effects of the patient's early
acute renal failure. However, since toxic effects are related to dose, it is reasonable
to assume that all possible measures to prevent absorption, increase excretion,
maintain the patient and prevent progressive organ damage are justified in cases
of this sort. They are unlikely to harm the patient, who may die for the lack of
them.
The following measures are therefore suggested in all cases in which the outcome
is unpredictable. They are based on what is known of the poison's absorption and
fate, and of the response of individual patients to treatment.
1. Immediate ejection of the swallowed dose followed by washing of the mouth
and inducement of vomiting.
2. Gastric lavage, although care is necessary to avoid the possibility of per-
foration of the oesophagus, which may be corroded (Malone et al, 1971).
3. Instillation of 1-2 litres of 7 per cent suspension of Bentonite as soon as
possible. Bentonite is a colloidal hydrated silicate, capable of removing
cationic substances from solution by a cation-exchange mechanism.
4. Transfer to an intensive care unit.
5. Encouragement of an oral diet, if tolerated, or tube-feeding, unless severe
oesophageal damage forbids it.
2116. Establishment of diuresis. If possible paraquat urinary excretion should be
measured daily.
7. Cyclophosphamide 3 mg./kg., and Prednisolone 1 mg./kg., daily, even though
the evidence that they help is inconclusive.
8. Peritoneal dialysis or haemodialysis especially if acute renal failure has
developed, when it is the only means of maintaining the patient and excreting
the poison.
9. Intensive respiratory care has been used in those surviving long enough or
requiring it. Recently, it has been suggested that far from being helpful,
oxygen therapy is definitely contra-indicated (Matthew, 1971; Fletcher, 1973).
Only from a survey of a large number of patients treated in this way can it be
known whether treatment contributes to survival in cases where the history makes
the prognosis unpredictable.
In cases where survival seems likely (such as numbers 1 and 2 in the cases
above) the regime may not need to be imposed. In cases where larger amounts
of highly concentrated paraquat are consumed, no present treatment is likely to
have any effect.
Paraquat has been marketed for 11 years, and the manufacturers record just
over 70 cases of fatal accidental poisoning by the concentrated liquid up to 1972.
There have been 11 fatal cases reported in Northern Ireland, of which 7 were
probably accidental. All the accidental deaths resulted from drinking concentrated
solution which had been decanted into unmarked bottles. The farming community
prefers to use the concentrated solution, because it is easy to store and is ready
for use in herbicidal sprayers. Manufacture of paraquat in a jelly form or as
concentrated granules has been considered and is much to be desired if it can be
made practicable. If not, the addition of a noxious smell to the concentrate might
prevent the unwary quaffing of decanted potions.
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